Eton Pharmaceuticals rises on Q2 profit beat

Eton Pharmaceuticals

14/08/2026 12:28

** Shares of Eton Pharmaceuticals  ETON.O rise 23% to $50.5 premarket
** Stock is set to snap a five-day losing streak if gains hold 
** Co late on Thursday posted Q2 profit of 42 cents per share, beating analysts' average estimate of 11 cents, according to data compiled by LSEG
** ETON raised its revenue guidance to about $145 million, analysts on average were expecting 2026 revenue of $136.27 million
** As of last close, stock more than doubled YTD 

 (Reporting by Padmanabhan Ananthan)
 ((Padmanabhan.Ananthan@thomsonreuters.com))